Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs
Rajiv Khanna(QIMR Berghofer Medical Research Institute), L Cooper, L M Poulsen(QIMR Berghofer Medical Research Institute), Scott Thomson(Centro de Estudos da Voz), Peter Cresswell(Yale University), Scott R. Burrows(Australian National University), Denis J. Moss(The University of Queensland)
Cited by 94
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
|Immunity|2003|323
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|313